Joe Lennerz, MD, PhD is the Chief Scientific Officer at BostonGene. Dr. Lennerz oversees the comprehensive product lifecycle management, data utilization and regulatory science for BostonGene, a leading provider of AI-driven molecular-genetic and immune profiling solutions. Before BostonGene, Dr. Lennerz served as the Associate Chief of Pathology and the Medical Director of the Center for Integrated Diagnostics at Massachusetts General Hospital (MGH) and Harvard Medical School. His leadership focused on overseeing all aspects of personalized diagnostics, ensuring the rapid clinical integration of innovative technologies. Dr. Lennerz completed his MD and a PhD in molecular medicine at the University of Erlangen, Germany. His background includes residency training in anatomic pathology at Washington University in St. Louis and fellowships in molecular genetic-, gastrointestinal-, and liver pathology at MGH and Harvard Medical School. Dr. Lennerz's expertise extends to regulatory science, molecular-genetic biomarkers, payer operations, and the financial sustainability of high-complexity diagnostics. He served as the principal investigator in the first FDA instrument precision study for a whole slide scanning system. His dedication to advancing healthcare and diagnostics is evident through his multifaceted contributions in academia, regulatory science, and personalized medicine.